External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ICML 2021
Roche and Genentech at

ICML 2021

June 18 - June 22
Virtual
www.icml.ch
16th International Conference on Malignant Lymphoma
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
06:00 PM
Duration 65mins Virtual
Unlocking the future: Searching for a cure for DLBCL
Georg Hess, Matthew Matasar, Christopher Fox
Haematology - Oncology | Diffuse Large B-Cell Lymphoma

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:45 PM
Duration 12mins Virtual
Glofitamab step-up dosing (SUD): Updated efficacy data show high complete response rates in heavily pretreated relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL) patients (pts)
Carlo-Stella C
Haematology - Oncology | Diffuse Large B-Cell Lymphoma - Relapsed Refractory Non Hodgkin Lymphoma

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 12mins Virtual
Venetoclax-obinutuzumab modulates clonal growth: Results of a population-based minimal residual disese model from the randomized CLL14 study
Al-Sawaf O
Haematology - Oncology | Chronic Lymphocytic Leukaemia

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 12mins Virtual
Genetic markers and outcome with front line obinutuzumab plus either chlorambucil or venetoclax - updated analysis of the CLL14 trial
Tausch E
Haematology - Oncology | Chronic Lymphocytic Leukaemia

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.